1325.3000 -0.80 (-0.06%)
NSE Jun 20, 2025 15:31 PM
Volume: 1.8M
 

1325.30
-0.06%
Axis Direct
We expect Consol Revenue amd Consol PAT CAGR 10.9% and 22.1% respectively over the period FY20-FY23E. Therfore, we recommend BUY Target Price INR 6,200 for DRRD (PE multiple of 28x to FY23E earnings).
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended